EMEA-002175-PIP01-17

Key facts

Active substance
  • Netarsudil
  • Latanoprost
Therapeutic area
Ophthalmology
Decision number
P/0281/2017
PIP number
EMEA-002175-PIP01-17
Pharmaceutical form(s)
  • Eye drops, solution
  • Solution
Condition(s) / indication(s)
Treatment of glaucoma
Route(s) of administration
Ocular use
Contact for public enquiries
Aerie Pharmaceuticals Ireland Ltd
Tel. +1 9495268700
E-mail: info@aeriepharma.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating